Four peptides studied for cellular aging: telomeres, mitochondria, and stress signaling
Cellular aging shows up in worn-out chromosome caps, mitochondria that make less energy, and cells that stop working properly. Four peptides in this library are studied against parts of this process. Epithalon is linked to telomere maintenance, while humanin, MOTS-c, and SS-31 are studied for mitochondrial function — but the human evidence is thin and uneven, and much of it comes from animals and cells.
1The biology of this goal
Every cell holds a set of chromosomes, and each chromosome ends in a protective cap called a telomere. These caps shorten every time a cell divides, and when they get too short the cell can no longer divide properly — so telomere length is used as a marker of how old a cell is. Inside cells are mitochondria, tiny structures that turn food and oxygen into usable energy. As we age, mitochondria make less energy and leak more harmful byproducts called reactive oxygen species, which damage the cell. Some cells also stop dividing but refuse to die, sitting around and releasing signals that inflame nearby tissue. The peptides here are studied for two of these threads: keeping telomeres longer, and keeping mitochondria working.
Animal and laboratory studies suggest epithalon can lengthen telomeres and support mitochondrial markers in aging cells.
Epithalon is a synthetic peptide of four amino acids, modeled on a natural substance from the pineal gland. Researchers report it can switch on telomerase — the enzyme that maintains the protective caps on chromosomes — and that in lab-grown human cells this lengthened telomeres. It is also described as an antioxidant that may help aging cells' mitochondria.
Epitalon is described as having anti-aging effects on mammalian cells that occur through induction of telomerase activity, leading to extension of telomere length.1
Telomere length is considered a biomarker of aging, is strongly linked to aging-related diseases, and maintaining it may contribute to healthy aging and longevity.1
Adding epithalon to telomerase-negative human fetal fibroblasts reactivated hTERT expression, restored telomerase activity, and produced measurable telomere elongation.3
A 2025 study by Siddiqui et al. reported dose-dependent telomere extension in normal epithelial and fibroblast cells through hTERT upregulation, while in cancer cell lines extension occurred mainly through the ALT pathway.3
In aging mouse oocytes, epitalon increased mitochondrial membrane potential and mitochondrial DNA copy number, decreased spindle defects and abnormal cortical granule distribution at 12h and 24h, and reduced apoptosis by 24h.2
What this doesn't establish
None of these findings come from human trials, and the cell and oocyte studies do not establish that epithalon slows aging or extends healthy lifespan in people.
Human trials of giving humanin as a drug have not been published, but observational human data and animal studies report links between humanin and healthy aging.
Humanin is a small peptide made from instructions inside the mitochondria's own DNA. It acts as a signal — a 'mitokine' — that mitochondria send out when under stress, helping protect cells and keep energy metabolism healthy. Its levels tend to fall with age, and higher levels are linked to longer, healthier life in animals.
Humanin signaling is described as mediating exercise- and diet-related health benefits including healthy aging, and a compensatory rise in its synthesis could preserve mitochondrial function and cellular vitality.4
Regular exercise increases humanin levels and is associated with increased lifespan; altered humanin levels are associated with aging and age-related metabolic, cardiovascular, and neurological diseases.4
In C. elegans, overexpression of humanin was sufficient to increase lifespan, dependent on daf-16/Foxo, and treating middle-aged mice twice weekly with the potent analogue HNG improved metabolic healthspan parameters and reduced inflammatory markers.5
Humanin levels generally decline with age across species but remain stable in the naked mole-rat, a model of negligible senescence.5
A potent humanin analogue was reported to block cardiac fibrosis in aging mice, but humanin and MOTS-c also exacerbated the senescence-associated secretory phenotype in senescent cells.6
What this doesn't establish
The human evidence is observational (correlations with age, longevity, and disease); no clinical trial establishes that administering humanin slows aging in people, and it may worsen the inflammatory secretions of already-senescent cells.
Animal and laboratory studies suggest MOTS-c improves metabolic and mitochondrial markers relevant to aging.
MOTS-c is a small 16-amino-acid peptide encoded inside mitochondrial DNA, discovered in 2015. Like humanin, it is a 'mitokine' that signals mitochondrial health. Its levels drop with age, and researchers study it for its effects on metabolism, energy use, and how the body handles glucose.
MOTS-c is a 16-amino-acid mitochondria-derived peptide co-expressed with mitochondria across tissues, with plasma levels that decrease with age.7,8
MOTS-c is described as having benefits for and therapeutic potential in aging, cardiovascular disease, insulin resistance, and inflammation.7,8
During metabolic stress MOTS-c transfers to the nucleus and directs nuclear gene expression to promote cell balance.8
MOTS-c is the mitochondria-derived peptide most associated with exercise and enhances energy expenditure, contributing to the anti-obesity effects of exercise training.9
What this doesn't establish
Sources note no effective clinical method of applying MOTS-c has been developed, so its benefits for slowing human aging remain unproven; it has also been reported to worsen the inflammatory secretory phenotype of senescent cells.
Animal and laboratory studies suggest SS-31 stabilizes mitochondrial membranes and restores energy production, with some tier-3 community and practitioner reports of effects on exercise capacity in older adults.
SS-31 (also called elamipretide) is a synthetic peptide that homes in on mitochondria, the cell's energy factories. It binds to cardiolipin, a special fat in the inner mitochondrial membrane that keeps the energy machinery organized. By protecting cardiolipin, it is studied for helping mitochondria make more energy and produce fewer harmful byproducts.
SS-31 is described as a mitochondria-targeting antioxidant that has no effect on normal mitochondria, acting selectively on dysfunctional ones.10
Kidney proximal tubules have high mitochondrial density due to ATP demands for solute reabsorption and electrolyte balance, one context in which SS-31 has been studied.10
SS-31 is reported to cross cell membranes and bind specifically to cardiolipin in the inner mitochondrial membrane, stabilizing and restoring energy (ATP) production and reducing oxidative stress at its source.11
SS-31 is reported to concentrate inside mitochondria where oxidative stress originates, and has been associated with enhanced exercise and endurance capacity in aging and skeletal muscle studies.12
What this doesn't establish
The specific claims about improving endurance and exercise capacity in aging come from lower-quality (tier 3) sources, and the evidence here does not establish that SS-31 slows overall biological aging in humans.
These four peptides are described as complementary rather than redundant because they act on different parts of cellular aging. Epithalon works mainly on telomeres and telomerase, while humanin, MOTS-c, and SS-31 all target mitochondria but by different routes: SS-31 physically stabilizes cardiolipin and the electron transport chain to preserve ATP and cut ROS at the source, humanin signals through receptors to trigger anti-apoptotic and cytoprotective programs, and MOTS-c acts upstream through AMPK activation and Nrf2 antioxidant responses. Because humanin and MOTS-c cover different arms of the same mitochondrial-stress response, they are often discussed together as a metabolic and longevity pairing, and each mitochondrial peptide pairs plausibly with epithalon's separate telomere-based mechanism. One caution worth noting from the evidence itself: both humanin and MOTS-c have been reported to intensify the inflammatory secretions of already-senescent cells, which is a separate consideration from their protective effects on healthy cells.
Humanin + SS-31
May be complementary
Both aim to protect mitochondria and reduce oxidative/ischemic injury, but by different means: SS-31 physically stabilizes the inner-membrane cardiolipin and electron-transport supercomplexes to preserve ATP output and cut ROS, whereas humanin signals through receptors to trigger anti-apoptotic and anti-inflammatory programs. One protects mitochondrial machinery directly, the other signals survival — a genuinely complementary combination.
Not fully established
Both peptides' mechanisms clearly support the complementary relationship with the claimed shared dimensions. The mechanism material explicitly establishes: (1) Both target mitochondrial_function—SS-31 directly stabilizes cardiolipin, cristae, and ETC supercomplexes to preserve ATP and reduce ROS; humanin enhances mitochondrial biogenesis and bioenergetics. (2) Both target anti_inflammatory—SS-31 modulates inflammation/pyroptosis; humanin reduces pro-inflammatory cytokines via JAK2/STAT3 and SIRT1. (3) The explanation accurately characterizes their distinct mechanisms: SS-31 acts through direct physical stabilization of inner-membrane structures and oxidative phosphorylation, while humanin acts through receptor signaling (FPR2/FPR3, gp130) to trigger cytoprotection and anti-apoptotic programs. These are genuinely different mechanistic approaches (direct structural vs. signaling-mediated) that converge on shared protective outcomes, meeting the definition of complementarity. The mechanisms do not contradict this relationship; they substantiate it.
Humanin + MOTS-c
May be complementary
Both humanin and MOTS-c are mitochondrial-derived peptides ('mitokines') that signal cellular stress and improve metabolism, but they work through different downstream routes — humanin is chiefly cytoprotective/anti-apoptotic (Bax inhibition, STAT3, PI3K/Akt) while MOTS-c drives AMPK activation and Nrf2 antioxidant responses. Together they cover complementary arms of the same mitochondrial-stress response, which is why they are often discussed as a metabolic/longevity pairing.
Not fully established
Both peptides' mechanisms clearly establish them as mitochondrial-derived peptides (mitokines) with distinct but complementary pathways. Humanin targets anti-apoptotic Bcl-2 family members and activates JAK2/STAT3 and PI3K/Akt, while MOTS-c activates AMPK and the Keap1-Nrf2 antioxidant axis. Both are explicitly tagged with mitochondrial_function and anti_inflammatory in their approved tags. The mechanisms support the claim of complementary action: humanin's cytoprotection via apoptosis inhibition and STAT3 signaling differs from MOTS-c's AMPK-driven metabolic remodeling and Nrf2-mediated antioxidant stress response. Both improve insulin sensitivity and glucose metabolism through different routes, and both are described as mitokines signaling cellular/mitochondrial stress. The shared dimensions (mitochondrial_function, anti_inflammatory) are directly supported by the tagged attributes and mechanism descriptions, and the explanation accurately reflects the distinct downstream pathways documented in each peptide's mechanism material.
Humanin + Epithalon
No known conflict in the research
Both are studied as geroprotective peptides that reduce oxidative stress and are reported to extend healthspan in animal models, but epithalon acts on telomerase/hTERT and circadian-melatonin gene regulation while humanin works through mitochondrial cytoprotection. Distinct anti-aging mechanisms with a shared longevity goal.
Not fully established
Both peptides' mechanisms support a complementary relationship focused on mitochondrial_function and geroprotection. Humanin is explicitly described as a 'mitokine' encoded in the mitochondrial genome that enhances mitochondrial biogenesis/bioenergetics and has approved tag 'mitochondrial_function.' Epithalon has the same approved tag 'mitochondrial_function' and includes antioxidant/mitochondrial ROS modulation in its pathways. Both are reported to extend lifespan/healthspan in animal models through distinct mechanisms—humanin via direct mitochondrial cytoprotection and anti-apoptosis, epithalon via telomerase activation and circadian-melatonin restoration. The explanation accurately characterizes these as complementary (non-overlapping but synergistic) approaches to geroprotection that both address mitochondrial function and oxidative stress, justifying the proposed relationship and shared dimension.
SS-31 + Epithalon
No known conflict in the research
SS-31 stabilizes cardiolipin and cuts mitochondrial ROS at the source, whereas Epithalon's reported benefits run through telomerase and general antioxidant/senescence pathways. Both reduce oxidative/mitochondrial aging burden via unrelated mechanisms, making them plausibly complementary.
Not fully established
Both peptides' mechanisms establish mitochondrial_function as a shared dimension through distinct pathways: SS-31 directly targets cardiolipin, mPTP, and ETC supercomplexes to reduce mitochondrial ROS production and preserve mitochondrial structure; Epithalon activates telomerase and antioxidant pathways while modulating mitochondrial ROS. The proposed relationship as 'complementary' is justified—they address mitochondrial aging burden through unrelated mechanisms (direct mitochondrial targeting vs. telomerase/antioxidant upregulation), making them mechanistically non-overlapping yet synergistic for the shared dimension of mitochondrial function. Both peptides' approved tags include 'mitochondrial_function,' confirming this shared dimension is recognized in their mechanism profiles.
SS-31 + MOTS-c
No known conflict in the research
Both aim to protect and improve mitochondria but by different routes: MOTS-c works upstream through AMPK activation and Nrf2/ARE antioxidant gene expression, while SS-31 physically stabilizes cardiolipin and the electron-transport-chain supercomplexes to reduce ROS at the source. These are non-overlapping mechanisms converging on the same goal of better mitochondrial function and lower oxidative stress, making them a plausibly synergistic pairing.
Not fully established
The mechanisms clearly establish both shared dimensions. (1) Mitochondrial_function: MOTS-c improves mitochondrial function via AMPK activation and metabolic pathway modulation (folate-methionine cycle disruption); SS-31 directly stabilizes cardiolipin, ETC supercomplexes, and ATP synthase to enhance oxidative phosphorylation and ATP synthesis. Both target mitochondrial function but through distinct routes. (2) Anti_inflammatory: MOTS-c has anti-inflammatory effects via STAT3/IL-10 regulation and Keap1-Nrf2 pathways; SS-31 modulates inflammation/pyroptosis through ferroptosis suppression and BDNF signaling. The explanation correctly identifies these as non-overlapping upstream (MOTS-c: gene expression/AMPK) versus downstream (SS-31: direct structural/bioenergetic) mechanisms converging on mitochondrial protection and ROS reduction. This is a valid complementary relationship supported by the provided mechanisms.
Epithalon + MOTS-c
No known conflict in the research
Both are longevity-oriented peptides converging on antioxidant defense and metabolic/mitochondrial health via distinct mechanisms — MOTS-c drives AMPK/PGC-1α mitochondrial biogenesis and NRF2 antioxidant response, while Epithalon works through telomerase, senescence-pathway, and circadian/antioxidant modulation. Complementary geroprotective strategies.
4Compounds we looked at and left out
These share some biology with this goal, so you may have seen them recommended for it. Here is what our own research says about each.
Semaglutide is linked to mitochondrial function, but in this compound that activity is about weight loss and obesity management.
“Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the natural gut hormone GLP-1. It tells the pancreas to release more insulin and less glucagon, but only when blood sugar is elevated, which lowers blood glucose with a low risk of hypoglycemia. It also acts on appetite regulation and slows the rate at which the stomach empties, leading to reduced food intake and weight loss.”— from its own profile
Cerebrolysin is linked to mitochondrial function, but in this compound that activity is about cognitive function and neuroprotection in neurological conditions.
“Researchers propose it protects neurons by reducing cell death, calming inflammation, lowering oxidative stress (free radicals), and supporting blood vessels in the brain.”— from its own profile
Noopept is linked to mitochondrial function, but in this compound that activity is about cognitive enhancement and neuroprotection.
“Animal and cell studies attribute its cognitive and neuroprotective actions to raising the neurotrophic factors BDNF and NGF, boosting acetylcholine signaling, reducing oxidative stress and glutamate excitotoxicity, and increasing HIF-1 activity.”— from its own profile
5What we can't tell you yet
This library does not yet cover two important parts of cellular aging for this goal: clearing out senescent (worn-out but non-dividing) cells, known as senolytic activity, and cellular cleanup through autophagy. No compound here is linked to either of those processes.
No compound in our library is currently linked to clearing senescent cells.
No compound in our library is currently linked to cellular cleanup (autophagy).
This brief reports what published research says about these compounds. It is information, not medical advice, and not a recommendation to use anything described here. Evidence quality varies by compound and is labelled throughout. Talk to a qualified clinician before acting on any of it.